Yamada T, Onishi H, Machida Y
Department of Drug Delivery Research, 2-4-41, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.
Yakugaku Zasshi. 2001 Mar;121(3):239-45. doi: 10.1248/yakushi.121.239.
Simple ketoprofen microspheres (MS) were prepared by the dry-in-oil method using ethylcellulose (EC) as a matrix polymer. Further, the microspheres modified by addition of polyethylene glycol (PEG) and hydroxypropyl cellulose (HPC), called MS-P and MS-H, respectively, were prepared. The in vitro release from MS, MS-P and MS-H was examined in the JP XIII second fluid, pH 6.8, at 37 degrees C and 60 rpm. Chitosan-coated ketoprofen microparticles (Chi-MP) were prepared by the precipitation of droplets of chitosan solution containing MS, and their adhesion to the rat small intestinal mucosa was tested. The plasma concentrations after duodenal administration were investigated for ketoprofen powder suspension, MS and Chi-MP. The particle size was raised with the increase in amount of ketoprofen added. The drug content and addition of PEG or HPC affected the drug release rate. The microspheres with moderate drug content, prepared by addition of modest amount of PEG, exhibited better gradual drug release. Chi-MP showed a good mucoadhesion. The maximum plasma concentration of ketoprofen for Chi-MP was less than one-third of that for ketoprofen powder suspension. Chi-MP tended to show the higher and steadier plasma level than MS.
采用油中干燥法,以乙基纤维素(EC)作为基质聚合物制备了简单的酮洛芬微球(MS)。此外,还制备了分别添加聚乙二醇(PEG)和羟丙基纤维素(HPC)改性的微球,分别称为MS-P和MS-H。在37℃、60转/分钟的条件下,于日本药局方第十三版第二液(pH 6.8)中考察了MS、MS-P和MS-H的体外释放情况。通过含有MS的壳聚糖溶液液滴沉淀法制备了壳聚糖包衣的酮洛芬微粒(Chi-MP),并测试了其对大鼠小肠黏膜的黏附性。考察了酮洛芬粉末混悬液、MS和Chi-MP十二指肠给药后的血药浓度。随着酮洛芬添加量的增加,粒径增大。药物含量以及PEG或HPC的添加影响药物释放速率。通过添加适量PEG制备的药物含量适中的微球表现出较好的药物缓释效果。Chi-MP表现出良好的黏膜黏附性。Chi-MP的酮洛芬最大血药浓度不到酮洛芬粉末混悬液的三分之一。Chi-MP的血药水平往往比MS更高且更稳定。